It is time to abandon the Milan criteria.
作者信息
Yoshizumi Tomoharu, Shirabe Ken, Mori Masaki
机构信息
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma, Japan.
出版信息
Hepatobiliary Surg Nutr. 2019 Feb;8(1):56-58. doi: 10.21037/hbsn.2018.10.08.
Abstract
摘要
相似文献
1
It is time to abandon the Milan criteria.
Hepatobiliary Surg Nutr. 2019 Feb;8(1):56-58. doi: 10.21037/hbsn.2018.10.08.
2
Comment on "Is It Time to Abandon the Milan Criteria?".
Ann Surg. 2019 Dec;270(6):e85. doi: 10.1097/SLA.0000000000003244.
3
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time.
Liver Transpl. 2006 Dec;12(12):1761-9. doi: 10.1002/lt.20884.
4
Examinations of Factors Influencing Survival of Liver Transplantation for Hepatocellular Carcinoma: A Single-Center Experience From Budapest.
Transplant Proc. 2015 Sep;47(7):2201-6. doi: 10.1016/j.transproceed.2015.07.026.
5
Hepatocellular cancer as indication for liver transplantation: pushing beyond Milan.
Curr Opin Organ Transplant. 2016 Apr;21(2):91-8. doi: 10.1097/MOT.0000000000000282.
6
Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.
Transplant Proc. 2012 Oct;44(8):2459-61. doi: 10.1016/j.transproceed.2012.07.004.
7
Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria.
Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):494-9. doi: 10.1016/s1499-3872(13)60078-8.
8
The timing of liver transplantation after primary hepatectomy for hepatocellular carcinoma: a special reference to recurrence pattern and Milan criteria.
Transplantation. 2008 Sep 15;86(5):641-6. doi: 10.1097/TP.0b013e3181814de2.
9
The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.
Transplant Proc. 2011 May;43(4):1272-4. doi: 10.1016/j.transproceed.2011.03.077.
10
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma.
J Vasc Interv Radiol. 2010 Aug;21(8):1197-204; quiz 204. doi: 10.1016/j.jvir.2010.04.018.
引用本文的文献
1
Curative liver transplantation after lung resection for advanced hepatocellular carcinoma with lung metastasis and inferior vena cava tumor thrombosis: a case report.
J Liver Cancer. 2021 Sep;21(2):181-186. doi: 10.17998/jlc.2021.09.08. Epub 2021 Sep 30.
2
Predictor of outcome after living donor liver transplantation for patients with hepatocellular carcinoma beyond the Japan criteria.
Ann Gastroenterol Surg. 2020 Apr 24;4(4):413-421. doi: 10.1002/ags3.12335. eCollection 2020 Jul.
本文引用的文献
1
Is it Time to Abandon the Milan Criteria?: Results of a Bicoastal US Collaboration to Redefine Hepatocellular Carcinoma Liver Transplantation Selection Policies.
Ann Surg. 2018 Oct;268(4):690-699. doi: 10.1097/SLA.0000000000002964.
2
Lymphocyte-to-Monocyte Ratio Is a Predictor of Survival After Liver Transplantation for Hepatocellular Carcinoma.
Liver Transpl. 2018 Nov;24(11):1603-1611. doi: 10.1002/lt.25204.
3
Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
J Hepatol. 2016 Apr;64(4):852-9. doi: 10.1016/j.jhep.2015.11.033. Epub 2015 Nov 30.
4
Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment.
J Hepatol. 2013 Jan;58(1):58-64. doi: 10.1016/j.jhep.2012.08.017. Epub 2012 Aug 25.
5
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria.
Gastroenterology. 2012 Oct;143(4):986-94.e3; quiz e14-5. doi: 10.1053/j.gastro.2012.05.052. Epub 2012 Jun 29.
6
Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.
Surg Today. 2012 Jan;42(1):1-7. doi: 10.1007/s00595-011-0058-8. Epub 2011 Nov 25.
7
A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation.
PLoS One. 2011;6(9):e25295. doi: 10.1371/journal.pone.0025295. Epub 2011 Sep 26.
8
Systematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteria.
Br J Surg. 2011 Sep;98(9):1201-8. doi: 10.1002/bjs.7561. Epub 2011 May 27.
9
Significance of des-gamma-carboxy prothrombin in selection criteria for living donor liver transplantation for hepatocellular carcinoma.
Am J Transplant. 2009 Oct;9(10):2362-71. doi: 10.1111/j.1600-6143.2009.02783.x. Epub 2009 Jul 29.
10
Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma.
Ann Surg. 2009 Jul;250(1):141-51. doi: 10.1097/SLA.0b013e3181a77e59.
Zotero 插件